Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen

Contraception

Volumn 75, Issue 6, 2007, Pages 444-449

  Coffee, Andrea L ^a   Sulak, Patricia J ^a   Kuehl, Thomas J ^a  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Drospirenone; Extended regimen; Hormone free interval; Hormone withdrawal symptoms; Oral contraceptive pills

Indexed keywords

DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ARTICLE; BLEEDING; BREAST TENDERNESS; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; MENSTRUAL CYCLE; MOOD; MUSCLE CRAMP; ORAL CONTRACEPTION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PELVIS PAIN SYNDROME; PREGNANCY; SPOTTING;

AFFECT; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; DRUG ADMINISTRATION SCHEDULE; ETHINYL ESTRADIOL; FEMALE; HEADACHE; HUMANS; MENSTRUATION; PATIENT SATISFACTION; PELVIC PAIN; PROSPECTIVE STUDIES; TEXAS; TREATMENT OUTCOME;

EID: 34248580500     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.01.014     Document Type: Article

References (29)

1. Mosher W.D., Martinez G.M., Chandra A., Abma J.C., and Wilson S.J. Use of contraception and use of family planning services in the United States: 1982-2002. CDC Advance Data No. 350, December 10, 2004. www.cdc.gov/nchs/data/ad/ad350.pdf [Accessed December 4, 2006]
2. Crosignani P., Olive D., Bergqvist A., and Luciano A. Advances in the management of endometriosis: an update for clinicians. Hum Reprod Update 12 (2006) 179-189
3. Davis A.R., Westhoff C., O'Connell K., and Gallagher N. Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial. Obstet Gynecol 106 (2005) 97-104
4. Roy S.N., and Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf 27 (2004) 75-90
5. Yonkers K.A., Brown C., Pearlstein T.B., Foegh M., Sampson-Landers C., and Rapkin A. Efficacy of a new low-dose oral contraceptive with drosperinone in premenstrual dysphoric disorder. Obstet Gynecol 106 (2005) 492-501
6. Sulak P.J., Buckley T., and Kuehl T.J. Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives. Contraception 73 (2006) 41-45
7. Sulak P.J., Carl J., Gopalakrishnan I., Coffee A., and Kuehl T.J. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding. Contraception 70 (2004) 281-287
8. Sulak P.J., Scow R.D., Preece C., Riggs M.W., and Kuehl T.J. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95 (2000) 261-266
9. Anderson F.D., and Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 68 (2003) 89-96
10. Kwiecien M., Edelman A., Michols M.D., and Jensen J.T. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 67 (2003) 9-13
11. Miller L., and Hughes J.P. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 101 (2003) 653-661
12. Sulak P.J., Kuehl T.J., Ortiz M., and Shull B.L. Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms. Am J Obstet Gynecol 186 (2002) 1142-1149
13. Sulak P.J., Cressman B.E., Waldrop E., Holleman S., and Kuehl T.J. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 89 (1997) 179-183
14. Cachrimanidou A.C., Hellberg D., Nilsson S., Waldenstrom U., Olsson S.E., and Sikstrom B. Long-interval treatment regimen with a desogestrel-containing oral contraceptive. Contraception 48 (1993) 205-216
15. Anderson F.D., Gibbons W., and Portman D. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial. Am J Obstet Gynecol 15 (2006) 192-196
16. Sulak P.J., Kuehl T.J., Coffee A., and Willis S. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen. Am J Obstet Gynecol 95 (2006) 935-941
17. Coffee A.L., Kuehl T.J., Willis S., and Sulak P.J. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen. Am J Obstet Gynecol 95 (2006) 1311-1319
18. Sulak P.J., Willis S.A., Kuehl T.J., Coffee A., and Clark J. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 47 (2007) 27-37
19. Spona J., Elstein M., Feichtinger W., Sullivan H., Ludicke F., Muller U., et al. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 54 (1996) 71-77
20. Schlaff W.D., Lynch A.M., Hughes H.D., Cedars M.I., and Smith D.L. Manipulation of the pill-free interval in oral contraceptive users: the effect on follicular suppression. Am J Obstet Gynecol 190 (2004) 943-951
21. Miller W.B., and Smith P.J. Elimination of the menses: psychosocial aspects. J Psychiatr Res 12 (1975) 153-166
22. Rutter W., Knight C., Vizzard J., Mira M., and Abraham S. Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill. Med J Aust 149 (1988) 417-419
23. den Tonkelaar I., and Oddens B. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, hormone replacement therapy. Contraception 59 (1999) 357-362
24. Andrist L.C., Hoyt J., Weinstein D., and McGibbon C. The need to bleed: women's attitudes and beliefs about menstrual suppression. J Am Acad Nurse Pract 16 (2004) 31-37
25. Andrist L.C., Arias R.D., Nucatola D., et al. Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception 70 (2004) 359-363
26. Association of Reproductive Health Professionals. Choosing when to menstruate: the role of extended contraception. Available at:. http://www.arhp.org/healthcareproviders/cme/onlinecme/extendedregimencp/index.cfm?ID=328 [Accessed May 30, 2006.]
27. Ferrero S., Abbamonte L.H., Giordano M., et al. What is the desired menstrual frequency of women without menstruation-related symptoms?. Contraception 73 (2006) 537-541
28. Weigratz I., Hommel H.H., Zimmermann T., and Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception 69 (2004) 37-42
29. Glasier A.F., Smith K.B., van der Spuy Z.M., et al. Amenorrhea associated with contraception - an international study on acceptability. Contraception 67 (2003) 1-8